CDH1 and ovarian cancer: Dysregulation of Wnt/β‐catenin can induce EMT in ovarian cancer, which is characterized by decreased expression of the epithelial marker, E‐cadherin, and increased levels of mesenchymal markers, such as vimentin (28).